Trials / Sponsors / Metro International Biotech, LLC
Metro International Biotech, LLC
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Tracing the Metabolic Flux of Orally Administered NAD+ Precursors Healthy Adults | Phase 1 | 2025-04-28 |
| Recruiting | Phase 1a Single Ascending Dose Study of MIB-725 in Healthy Adults Healthy Adults | Phase 1 | 2025-02-11 |
| Completed | Effects of MIB-626 With and Without A High-Intensity Multi-Dimensional Exercise Training Program Healthy | Phase 2 | 2023-10-25 |
| Completed | Phase 2a MIB-626 vs. Placebo COVID-19 Covid19, Stage 1 Acute Kidney Injury | Phase 2 | 2021-10-26 |
| Completed | NAD+ Precursor Supplementation in Friedreich's Ataxia Friedreich Ataxia | Phase 2 | 2021-05-17 |